Skip to main content

Alphadyne Asset Management LP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1535943 NEW YORK, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$29,929
-$552,641 QoQ
Shares Held
48
-93.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,162
of 1,327 holders
Holding Since
Sep 2023
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Jun 30, 2026
CallValue
$4,240,072
CallShares
6,800
PutValue
$1,247,080
PutShares
2,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Alphadyne Asset Management LP holds $66,190 across 2 Biotechnology names. REGN ranks #2 (45.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
48 $29,929

All Filings in REGN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $29,929 48
2026-06-30 $1,247,080 2,000
2026-06-30 $4,240,072 6,800
2026-03-31 $5,640,272 7,300
2026-03-31 $4,558,576 5,900
2026-03-31 $582,570 754
2025-12-31 $3,473,415 4,500
2025-12-31 $2,855,919 3,700
2025-09-30 $285,633 508
2025-09-30 $1,855,491 3,300
2025-09-30 $899,632 1,600
2023-09-30 $1,069,848 1,300
2023-09-30 $237,835 289